BAKER BROS. ADVISORS LP

Director; Director, 10% Owner · 15 filings · Latest: Jun 26, 2026

ACADIA PHARMACEUTICALS INC

BeOne Medicines Ltd.

Denali Therapeutics Inc.

INCYTE CORP

Kiniksa Pharmaceuticals International, plc

Kymera Therapeutics, Inc.

MADRIGAL PHARMACEUTICALS, INC.

Prelude Therapeutics Inc

Replimune Group, Inc.

TScan Therapeutics, Inc.

vTv Therapeutics Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ONC	BAKER BROS. ADVISORS LP	Director	May 22, 2026	Sale	$23.82	10,998	$262.0K	142,570	May 27 8:54 PM
INCY	BAKER BROS. ADVISORS LP	Director, 10% Owner	May 8, 2026	Option Exercise	$84.53	30,000	$2.5M	28,203,718	May 11 8:45 PM